tradingkey.logo

tradingkey.logo
怜玢


Oncology Institute Inc

TOI
りォッチリストに远加
4.000USD
+0.020+0.50%
終倀 05/18, 16:00ET15分遅れの株䟡
399.90M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Oncology Institute Inc 䌁業名

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Incの䌁業情報


䌁業コヌドTOI
䌚瀟名Oncology Institute Inc
䞊堎日Mar 13, 2020
最高経営責任者「CEO」Virnich (Daniel)
埓業員数825
蚌刞皮類Ordinary Share
決算期末Mar 13
本瀟所圚地18000 Studebaker Rd
郜垂CERRITOS
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号90703
電話番号15627353226
りェブサむトhttps://theoncologyinstitute.com/
䌁業コヌドTOI
䞊堎日Mar 13, 2020
最高経営責任者「CEO」Virnich (Daniel)

Oncology Institute Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
715.98K
-145.44%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
69.05K
-252.61%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
51.29K
-711.93%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
715.98K
-145.44%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
69.05K
-252.61%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
51.29K
-711.93%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
事業別USD
䌚瀟名
収益
比率
Dispensary revenue
269.18M
53.54%
FFS revenue
148.51M
29.54%
Capitated revenue
80.48M
16.01%
Clinical research trials and other revenue
4.56M
0.91%
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Dispensary revenue
269.18M
53.54%
FFS revenue
148.51M
29.54%
Capitated revenue
80.48M
16.01%
Clinical research trials and other revenue
4.56M
0.91%

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Chernett (Jorey)
10.50%
M33 Growth LLC
5.45%
OncologyCare Partners LLC
4.11%
Parian Global Management LP
3.55%
Vanguard Capital Management, LLC
3.48%
他の
72.91%
株䞻統蚈
株䞻統蚈
比率
Chernett (Jorey)
10.50%
M33 Growth LLC
5.45%
OncologyCare Partners LLC
4.11%
Parian Global Management LP
3.55%
Vanguard Capital Management, LLC
3.48%
他の
72.91%
皮類
株䞻統蚈
比率
Investment Advisor
15.57%
Individual Investor
14.00%
Hedge Fund
13.03%
Investment Advisor/Hedge Fund
10.32%
Venture Capital
5.49%
Corporation
4.11%
Research Firm
1.51%
Private Equity
0.25%
Bank and Trust
0.16%
他の
35.55%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
204
47.47M
47.57%
-10.14M
2025Q4
172
39.89M
40.55%
-15.45M
2025Q3
145
39.72M
42.48%
-7.79M
2025Q2
119
39.72M
44.51%
-19.63M
2025Q1
137
46.36M
52.04%
-13.47M
2024Q4
138
45.05M
59.62%
-19.81M
2024Q3
139
50.89M
67.39%
-11.59M
2024Q2
143
57.80M
76.77%
-3.05M
2024Q1
146
56.10M
75.87%
-3.90M
2023Q4
143
57.48M
77.79%
-4.30M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Chernett (Jorey)
10.48M
10.6%
+5.36M
+104.88%
Mar 27, 2026
M33 Growth LLC
5.44M
5.51%
-3.08M
-36.13%
Nov 18, 2025
OncologyCare Partners LLC
4.11M
4.16%
--
--
Mar 26, 2025
BlackRock Institutional Trust Company, N.A.
3.48M
3.52%
+358.84K
+11.51%
Dec 31, 2025
Deerfield Management Company, L.P.
3.36M
3.4%
--
--
Dec 31, 2025
Kanen Wealth Management, LLC
2.98M
3.01%
+1.13M
+61.56%
Dec 31, 2025
Balyasny Asset Management LP
2.52M
2.55%
+100.00
+0.00%
Dec 31, 2025
Josh Arnold Investment Consultant, LLC
2.46M
2.49%
+2.26M
+1104.31%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Vanguard US Momentum Factor ETF
0.11%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Vanguard US Momentum Factor ETF
比率0.11%
iShares Micro-Cap ETF
比率0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.03%
Global X Russell 2000 ETF
比率0.01%
ProShares Hedge Replication ETF
比率0.01%
iShares Russell 2000 ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
ProShares UltraPro Russell2000
比率0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.01%
iShares Russell 2000 Growth ETF
比率0.01%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™